RECBIO-B Converts 141.95 Million Internal Shares to H Shares, Enlarging Hong Kong Float by 44.9%

Bulletin Express04-30

Jiangsu Recbio Technology Co., Ltd. (RECBIO-B) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 30 April 2026, detailing a major adjustment to its share structure.

On 29 April 2026, the company converted 129.95 million domestic shares and 12.00 million unlisted foreign shares into 141.95 million H shares. The transaction involved no new cash proceeds and represented a reclassification within the existing share capital.

Following the conversion, the number of H shares in issue increased from 316.14 million to 458.09 million, a rise of 44.90%. Domestic shares fell to 167.98 million, and all unlisted foreign shares were eliminated. Total issued share capital remained unchanged at 626.08 million shares.

The company reported no treasury shares, repurchases, or cancellations as of the closing balance date.

Director Liu Yong confirmed that the board duly authorised the conversion and that all procedures complied with Hong Kong listing rules and relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment